Search Results - "Mira, JA"

HAART and the liver: friend or foe? by Pineda, J A, Macías, J, Mira, J A, Merchante, N, del Valle, J, Neukam, K I

“…The overall effect of HAART on the liver is the result of the balance between hepatotoxicity and the consequences of immunoreconstitution on the evolution of…”
Get full text

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine by Macias, J, Castellano, V, Merchante, N, Palacios, R B, Mira, JA, Saez, C, Garcia-Garcia, JA, Lozano, F, Gomez-Mateos, J M, Pineda, JA

“…Background: The hepatotoxicity of highly active antiretroviral therapy (HAART) could enhance liver fibrosis in HIV/Hepatitis C virus (HCV)-coinfected patients…”
Get full text

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes by Macías, J, Girón-González, J A, González-Serrano, M, Merino, D, Cano, P, Mira, J A, Arizcorreta-Yarza, A, Ruíz-Morales, J, Lomas-Cabeza, J M, García-García, J A, Corzo, J E, Pineda, J A

“…Background: Liver biopsy is an invasive technique with associated major complications. There is no information on the validity of five non-invasive indexes…”
Get full text

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine by Merchante, Nicolás, Pérez-Camacho, Inés, Mira, José A, Rivero, Antonio, Macías, Juan, Camacho, Angela, Gómez-Mateos, Jesús, García-Lázaro, Milagros, Torre-Cisneros, Julián, Pineda, Juan A

“…Unexpected cases of severe liver disease in HIV-infected patients have been reported and an association with didanosine (ddI) has been suggested. Transient…”
Get more information

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV―hepatitis C virus-coinfected patients with prior nonresponse or relapse by LABARGA, Pablo, BARREIRO, Pablo, RIVERO, Antonio, BENITO, José M, PINEDA, Juan A, SORIANO, Vincent, MIRA, Jose A, VISPO, Eugenia, RALLON, Norma, NEUKAM, Karin, CAMACHO, Angela, CARUZ, Antonio, RODRIGUEZ-NOVOA, Sonia, PINILLA, Javier

“…IL28B polymorphisms predict treatment response in chronic hepatitis C. However, no information exists in prior treatment failures. A total of 62 HIV/hepatitis…”
Get full text

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients by MIRA, José A, RIVERO, Antonio, OMAR, Mohamed, RIVERO-JUAREZ, Antonio, MACIAS, Juan, PINEDA, Juan A, LOS SANTOS-GIL, Ignacio De, LOPEZ-CORTES, Luis F, GIRON-GONZALEZ, Jose A, MARQUEZ, Manuel, MERINO, Dolores, MAR VILORIA, María Del, TELLEZ, Francisco, RIOS-VILLEGAS, Marfa J

“…We assess the efficacy of pegylated interferon (peg-IFN) with ribavirin (RBV) and the predictors of sustained virological response (SVR) among HIV/hepatitis C…”
Get full text

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir by VISPO, Eugenia, BARREIRO, Pablo, RIVERO, Antonio, SORIANO, Vincent, PINEDA, Juan A, MIRA, José A, MAIDA, Ivana, MARTIN-CARBONERO, Luz, RODRIGUEZ-NOVOA, Sonia, SANTOS, Ignacio, LOPEZ-CORTES, Luis F, MERINO, Dolores

“…There is little information about the influence of antiretroviral drugs on the antiviral activity of pegylated interferon (PEG-IFN) plus ribavirin (RBV)…”
Get full text

Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection by Di Lello, F. A, Mira, J. A, Neukam, K, Parra-Sánchez, M, Guelfo, J. R, Cifuentes, C, Macías, J, Palomares, J. C, Gómez-Mateos, J, Pineda, J. A, Real, Luis M

“…The aim of this study was to analyze the impact of core variations on sustained virological response (SVR) to pegylated interferon plus ribavirin (PEG-IFN/RBV)…”
Get full text

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia by Mira, J. A., Neukam, K., López-Cortés, L. F., Rivero-Juárez, A., Téllez, F., Girón-González, J. A., de los Santos-Gil, I., Ojeda-Burgos, G., Merino, D., Ríos-Villegas, M. J., Collado, A., Torres-Cornejo, A., Macías, J., Rivero, A., Pérez-Pérez, M., Pineda, J. A.

“…The aim of this study was to assess the efficacy of and the risk of major bleeding during pegylated interferon (peg-IFN)/ribavirin (RBV) treatment among human…”
Get full text

Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV by Rivero-Juarez, A., Mira, J. A., Camacho, A., Neukam, K., Perez-Camacho, I., Caruz, A., Macias, J., Torre-Cisneros, J., Pineda, J. A., Rivero, A.

“…Purpose Hepatitis C virus (HCV) viral relapse (VR) after end-of-treatment response (ETR) in human immunodeficiency virus (HIV) co-infected patients is observed…”
Get full text

Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients: Noninvasive diagnosis of fibrosis by Macías, J, Mira, JA, Gilabert, I, Neukam, K, Roldán, C, Viloria, MaMar, Moro, A, Pineda, JA

Get full text

Different distributions of hepatitis C virus genotypes among HIV‐infected patients with acute and chronic hepatitis C according to interleukin‐28B genotype by Neukam, K, Nattermann, J, Rallón, N, Rivero, A, Caruz, A, Macías, J, Vogel, M, Benito, JM, Camacho, Á, Mira, JA, Schwarze‐Zander, C, Barreiro, P, Martínez, A, Rockstroh, JK, Soriano, V, Pineda, JA

“…Objectives The C allele of the single nucleotide polymorphism rs12979860, located near the interleukin‐28B (IL‐28B) gene, has a strong impact on hepatitis C…”
Get full text

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients by VAN DEN EYNDE, Eva, TIRABOSCHI, Juan Manuel, CRESPO, Manuel, TURAL, Cristina, SOLA, Ricard, MIRA, José Antonio, PODZAMCZER, Daniel, JOU, Antoni, CANETE, Nuria, PINEDA, Juan Antonio, PAHISSA, Albert

“…Guidelines recommendation to extend treatment duration in genotype 1 hepatitis C virus (HCV)/HIV-coinfected patients who clear the virus later than treatment…”
Get full text

Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus‐coinfected patients by Macías, J, Mira, JA, Gilabert, I, Neukam, K, Roldán, C, Viloria, MaMar, Moro, A, Pineda, JA

“…Objective Noninvasive tests that can be used in place of liver biopsy to diagnose fibrosis have major limitations. They either leave a significant proportion…”
Get full text

Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment by Neukam, K., Mira, J. A., Gilabert, I., Claro, E., Vázquez, M. J., Cifuentes, C., García-Rey, S., Merchante, N., Almeida, C., Macías, J., Pineda, J. A.

“…A considerable number of patients undergoing methadone maintenance treatment (MMT) are not considered for treatment against hepatitis C virus (HCV) infection…”
Get full text

Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression by Mira, José A., Gutiérrez-Valencia, Alicia, Ignacio de los Santos, Gil, Dolores, Merino, Rivero, Antonio, Ríos-Villegas, María J., Delgado, Marcial, González-Serrano, Mercedes, Collado, Antonio, Torres-Tortosa, Manuel, Omar, Mohamed, López-Ruz, Miguel Ángel, Macías, Juan, Arponen, Sari, Pineda, Juan A.

“…Background. The aim of this study was to assess the efficacy and safety of pegylated interferon (IFN) plus ribavirin (RBV) in human immunodeficiency virus…”
Get full text

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype: HCV and IL-28B genotype distribution by Neukam, K, Nattermann, J, Rallón, N, Rivero, A, Caruz, A, Macías, J, Vogel, M, Benito, JM, Camacho, Á, Mira, JA, Schwarze-Zander, C, Barreiro, P, Martínez, A, Rockstroh, JK, Soriano, V, Pineda, JA

Get full text

Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients by DEL VALLE, José, MIRA, José A, GARCIA-GARCIA, José A, PINEDA, Juan A, DELOS SANTOS, Ignacio, LOPEZ-CORTES, Luis F, MERINO, Dolores, RIVERO, Antonio, GIRON, José A, RIOS-VILLEGAS, Maria J, GONZALEZ-SERRANO, Mercedes, COLLADO, Antonio

“…High levels of serum low-density lipoprotein cholesterol are associated with better response to pegylated interferon and ribavirin in hepatitis C virus…”
Get full text

Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy by MACIAS, J, MELGUIZO, I, FERNANDEZ-RIVERA, F. J, GARCIA-GARCIA, A, MIRA, J. A, RAMOS, A. J, RIVERA, J. M, PINEDA, J. A

“…The aim of the present study was to examine the causes of death, the mortality attributable to liver failure, and the impact of hepatitis virus infections on…”
Get full text

Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir by Pineda, Juan A., Palacios, Rosario, Rivero, Antonio, Abdel-kader, Laila, Márquez, Manuel, Cano, Pilar, Mira, José A., Torre-Cisneros, Julián, Lozano, Fernando, Santos, Jesús

Get full text